TSVT Insider Trading
Insider Ownership Percentage: 7.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $25,462,068.53
2seventy bio Insider Trading History Chart
This chart shows the insider buying and selling history at 2seventy bio by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
2seventy bio Share Price & Price History
Current Price: $4.98
Price Change: ▲ Price Increase of +0.01 (0.20%)
As of 04/17/2025 05:00 PM ET
2seventy bio Insider Trading History
2seventy bio Institutional Trading History
Data available starting January 2016
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes Abecma, a chimeric antigen receptor T-cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
Read More on 2seventy bio
Volume
444,665 shs
Average Volume
617,204 shs
Market Capitalization
$260.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.04
Who are the company insiders with the largest holdings of 2seventy bio?
2seventy bio's top insider investors include:
- Kynam Capital Management, Lp (Major Shareholder)
- Casdin Capital, Llc (Director)
- Nick Leschly (CEO)
- William D Baird III (CEO)
- Victoria Eatwell (CFO)
- Philip D Gregory (Insider)
- Jessica Snow (COO)
- William D Baird III (CFO)
- William D Baird III (COO)
- Jessica Snow (Insider)
- Marcela V Maus (Director)
- Global Healthcare Master Kynam (Major Shareholder)
Learn More about top insider investors at 2seventy bio.
Who are the major institutional investors of 2seventy bio?
Which major investors are selling 2seventy bio stock?
During the previous quarter, TSVT stock was sold by these institutional investors:
- Exchange Traded Concepts LLC
In the previous year, company insiders that have sold 2seventy bio company stock include:
- Kynam Capital Management, Lp (Major Shareholder)
- Casdin Capital, Llc (Director)
- Nick Leschly (CEO)
- William D Baird III (CEO)
- Victoria Eatwell (CFO)
- Philip D Gregory (Insider)
Learn More investors selling 2seventy bio stock.